- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Use of a next generation maleimide in combination with THIOMAB™ antibody technology delivers a highly stable, potent and near homogeneous THIOMAB™ antibody-drug conjugate (TDC)
-
- João P. M. Nunes
- Department of Chemistry
-
- Vessela Vassileva
- UCL Cancer Institute
-
- Eifion Robinson
- Department of Chemistry
-
- Maurício Morais
- Department of Chemistry
-
- Mark E. B. Smith
- Department of Chemistry
-
- R. Barbara Pedley
- UCL Cancer Institute
-
- Stephen Caddick
- Department of Chemistry
-
- James R. Baker
- Department of Chemistry
-
- Vijay Chudasama
- Department of Chemistry
Description
<p>Conjugation of next generation maleimides to engineered cysteines in a THIOMAB™ antibody delivers a highly stable and potent THIOMAB™ antibody-drug conjugate.</p>
Journal
-
- RSC Advances
-
RSC Advances 7 (40), 24828-24832, 2017
Royal Society of Chemistry (RSC)
- Tweet
Details 詳細情報について
-
- CRID
- 1360292619065313024
-
- ISSN
- 20462069
-
- Data Source
-
- Crossref